Company Data
Panbela Therapeutics Inc.
Ticker
PBLA
Current Price
$0.34 6.27%
Market Cap
$1.7M
Price Target
Refer to Report
Volume
27.5K
52wk Range
$0.3 - $1.5
Overview
Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications.